BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 16024603)

  • 1. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
    Jansen AP; Camalier CE; Colburn NH
    Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
    Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
    Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice.
    Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D
    Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.
    Yang HS; Jansen AP; Nair R; Shibahara K; Verma AK; Cmarik JL; Colburn NH
    Oncogene; 2001 Feb; 20(6):669-76. PubMed ID: 11314000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDCD4 inhibits the malignant phenotype of ovarian cancer cells.
    Wei ZT; Zhang X; Wang XY; Gao F; Zhou CJ; Zhu FL; Wang Q; Gao Q; Ma CH; Sun WS; Fu QZ; Chen YH; Zhang LN
    Cancer Sci; 2009 Aug; 100(8):1408-13. PubMed ID: 19493270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction.
    Yasuda M; Nishizawa T; Ohigashi H; Tanaka T; Hou DX; Colburn NH; Murakami A
    Carcinogenesis; 2009 Jul; 30(7):1209-16. PubMed ID: 19414503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
    Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
    Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.
    Gebhardt C; Breitenbach U; Tuckermann JP; Dittrich BT; Richter KH; Angel P
    Oncogene; 2002 Jun; 21(27):4266-76. PubMed ID: 12082614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice.
    Hwang SK; Jin H; Kwon JT; Chang SH; Kim TH; Cho CS; Lee KH; Young MR; Colburn NH; Beck GR; Yang HS; Cho MH
    Gene Ther; 2007 Sep; 14(18):1353-61. PubMed ID: 17611588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
    Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
    Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
    Yang HS; Knies JL; Stark C; Colburn NH
    Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
    Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
    Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.